In this study, inhibition of Ca2+ signaling via TRPC6 inhibition resulted in restored sensitivity of HCC cells to various chemotherapeutic drugs and attenuation of the epithelial–mesenchymal transition [76]. The gene discussed is TRPC6; the disease is hepatocellular carcinoma.